Literature DB >> 21130075

Determining the binding mode and binding affinity constant of tyrosine kinase inhibitor PD153035 to DNA using optical tweezers.

Chih-Ming Cheng1, Yuarn-Jang Lee, Wei-Ting Wang, Chien-Ting Hsu, Jing-Shin Tsai, Chien-Ming Wu, Keng-Liang Ou, Tzu-Sen Yang.   

Abstract

Accurately predicting binding affinity constant (K(A)) is highly required to determine the binding energetics of the driving forces in drug-DNA interactions. Recently, PD153035, brominated anilinoquinazoline, has been reported to be not only a highly selective inhibitor of epidermal growth factor receptor but also a DNA intercalator. Here, we use a dual-trap optical tweezers to determining K(A) for PD153035, where K(A) is determined from the changes in B-form contour length (L) of PD153035-DNA complex. Here, L is fitted using a modified wormlike chain model. We found that a noticeable increment in L in 1 mM sodium cacodylate was exhibited. Furthermore, our results showed that K(A)=1.18(±0.09)×10(4) (1/M) at 23±0.5°C and the minimum distance between adjacent bound PD153035≈11 bp. We anticipate that by using this approach we can determine the complete thermodynamic profiles due to the presence of DNA intercalators. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21130075     DOI: 10.1016/j.bbrc.2010.11.110

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Platinum-Based Drugs and DNA Interactions Studied by Single-Molecule and Bulk Measurements.

Authors:  Domenico Salerno; Giovanni L Beretta; Giuliano Zanchetta; Simone Brioschi; Matteo Cristofalo; Natalia Missana; Luca Nardo; Valeria Cassina; Alessia Tempestini; Roberto Giovannoni; Maria Grazia Cerrito; Nadia Zaffaroni; Tommaso Bellini; Francesco Mantegazza
Journal:  Biophys J       Date:  2016-05-24       Impact factor: 4.033

2.  Profound Nanoscale Structural and Biomechanical Changes in DNA Helix upon Treatment with Anthracycline Drugs.

Authors:  Aleksandra Kaczorowska; Weronika Lamperska; Kaja Frączkowska; Jan Masajada; Sławomir Drobczyński; Marta Sobas; Tomasz Wróbel; Kinga Chybicka; Radosław Tarkowski; Sebastian Kraszewski; Halina Podbielska; Wojciech Kałas; Marta Kopaczyńska
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.